Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Granular Therapeutics Limited

Clinical trials sponsored by Granular Therapeutics Limited, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug aims to calm stubborn hives triggered by cold or scratching Results expected Aug 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New drug aims to calm stubborn hives triggered by cold or scratching

Symptom relief Recruiting now

This early-stage study tests a single dose of an experimental drug called GTX-B001 in healthy people and those with chronic inducible urticaria—a condition where cold or scratching causes painful hives. The main goal is to check safety and how the body handles the drug. About 72 …

Phase 1 • Sponsor: Granular Therapeutics Limited • Aim: Symptom relief

Last updated Sep 10, 2026 07:00 UTC